Opinion: CDC panel compares the U.S. hepatitis B child vaccine schedule to Denmark’s — but omits crucial context

The CDC’s Advisory Committee on Immunization Practices meeting last week marked an abrupt shift in hepatitis B policy in the U.S., with implications that reach far beyond a single line on the childhood vaccination schedule.

Until now, the U.S. recommended a simple universal birth dose of a hepatitis B vaccine for every newborn precisely because prenatal care, insurance coverage and medical records are so variable in our fragmented system.